Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06506968 · ClinicalTrials.gov registry record

Ergonomics in the Cardiac Catheterization Laboratory

A clinical trial of Wellness and Ergonomics, sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
30
Enrollment target
1
Study location

NCT06506968: Recruiting study of Wellness and Ergonomics, sponsored by Brigham and Women's Hospital.

NCT06506968 is a study of Wellness and Ergonomics that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 30 participants, below the 4,139-participant average among 5 other Wellness trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06506968, a study of Wellness and Ergonomics, is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to quantify ergonomic risk associated with traditional protective equipment in operators working in the cardiac catheterization laboratory as compared with a mobile protection system. The main questions it aims to answer is: What is the mean time spent by operators in positions of high ergonomic postural risk during cases? Participants will wear IMU, EMG, and radiation sensors, as well as complete baseline and discomfort surveys for several catheterization procedures.

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-05-13
Est. Completion 2024-12
Brigham and Women's Hospital

937 total trials

What NCT06506968 shows while recruiting

NCT06506968 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 4,139-participant average among 5 other Wellness trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Wellness appearing as the primary indexed condition, and to 0 interventions.

NCT06506968 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06506968 about?

NCT06506968 is a clinical study titled "Ergonomics in the Cardiac Catheterization Laboratory". The goal of this observational study is to quantify ergonomic risk associated with traditional protective equipment in operators working in the cardiac catheterization laboratory as compared with a mobile protection system. The main questions it aims to answer is: What is the mean time spent by ope...

What is the current status of trial NCT06506968?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2024-05-13. Estimated completion is 2024-12.

What conditions does trial NCT06506968 study?

This clinical trial studies the following conditions: Wellness, Ergonomics, Orthopedic Injury.

Who is sponsoring clinical trial NCT06506968?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06506968 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wellness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06506968, the US trial registry maintained by the National Library of Medicine. NCT06506968 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.